Table 3.

Clinical response to adoptive transfer of T cells transduced with anti-NY-ESO-1 TCR

n (%) of patients (duration in mo)
Tumor typeTotalPRCROR
Synovial cell sarcoma1810 (55)1 (6)11 (61)
47+, 18, 11, 10, 8, 7, 5, 4, 3, 320+
Melanoma207 (35)4 (20)11 (55)
28, 10, 8, 6+, 5, 3, 358+, 54+, 40+, 24

NOTE: Response data updated as of December 1, 2014, or the last follow-up date.

Abbreviations: PR, partial response; CR, complete response; OR, objective response.